Harvard Bioscience, Inc. (HBIO)
8.24
+0.11
(+1.35%)
USD |
NASDAQ |
Oct 09, 16:00
Harvard Bioscience Free Cash Flow (Quarterly) : -0.593M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.593M |
| March 31, 2026 | -1.411M |
| December 31, 2025 | -0.008M |
| September 30, 2025 | 0.482M |
| June 30, 2025 | 2.218M |
| March 31, 2025 | 2.174M |
| December 31, 2024 | 1.259M |
| September 30, 2024 | -1.953M |
| June 30, 2024 | -1.812M |
| March 31, 2024 | 0.683M |
| December 31, 2023 | 3.242M |
| September 30, 2023 | 3.96M |
| June 30, 2023 | 2.927M |
| March 31, 2023 | 1.588M |
| December 31, 2022 | 2.444M |
| September 30, 2022 | 0.207M |
| June 30, 2022 | -0.632M |
| March 31, 2022 | -2.457M |
| December 31, 2021 | -0.241M |
| September 30, 2021 | -1.038M |
| June 30, 2021 | 0.46M |
| March 31, 2021 | 0.736M |
| December 31, 2020 | 2.426M |
| September 30, 2020 | 1.033M |
| June 30, 2020 | 2.09M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.63M |
| December 31, 2019 | 1.797M |
| September 30, 2019 | 2.797M |
| June 30, 2019 | 0.377M |
| March 31, 2019 | 1.858M |
| December 31, 2018 | 2.502M |
| September 30, 2018 | -1.691M |
| June 30, 2018 | 1.125M |
| March 31, 2018 | -0.058M |
| December 31, 2017 | -1.152M |
| September 30, 2017 | 1.891M |
| June 30, 2017 | 0.227M |
| March 31, 2017 | -0.838M |
| December 31, 2016 | 1.202M |
| September 30, 2016 | 2.888M |
| June 30, 2016 | 0.741M |
| March 31, 2016 | -0.927M |
| December 31, 2015 | 1.102M |
| September 30, 2015 | -0.736M |
| June 30, 2015 | -1.08M |
| March 31, 2015 | -1.541M |
| December 31, 2014 | 0.482M |
| September 30, 2014 | 0.122M |
| June 30, 2014 | 0.952M |
| March 31, 2014 | 0.79M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 439.00M |
| Bio-Rad Laboratories, Inc. | 66.70M |
| Bruker Corp. | -106.20M |
| Danaher Corp. | 1.265B |
| Illumina, Inc. | 159.00M |